288
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Quality of Life After Treatment for Pelvic Organ Prolapse: Vaginal Pessary versus Surgery

, & ORCID Icon
Pages 1017-1025 | Received 26 Jan 2023, Accepted 11 Jul 2023, Published online: 12 Jul 2023

References

  • Barber MD, Maher CF. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogyn J. 2013;24:1783–1790. doi:10.1007/s00192-013-2169-9
  • Chuenchompoonut V, Bunyavejchevin S, Wisawasukmongchol W, Taechakraichana N. Prevalence of genital prolapse in Thai menopausal women (using new standardization classification). J Med Assoc Thai. 2005;88:1–4.
  • Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogyn J. 2016;27:165–194. doi:10.1007/s00192-015-2932-1
  • Zhu Q, Shu H, Dai Z. Effect of pelvic floor dysfunction on sexual function and quality of life in Chinese women of different ages: an observational study. Geriatr Gerontol Int. 2019;19:299–304. doi:10.1111/ggi.13618
  • Brandt C, Janse van Vuuren EC. Dysfunction, activity limitations, participation restriction and contextual factors in South African women with pelvic organ prolapse. S Afr J Physiother. 2019;75:933–940. doi:10.4102/sajp.v75i1.933
  • Anantawat T, Manonai J, Wattanayingcharoenchai R, Sarit-apirak S. Impact of a vaginal pessary on the quality of life in women with pelvic organ prolapse. Asian Biomed. 2016;10:249–252.
  • Bugge C, Adams EJ, Gopinath D, et al. Pessaries (mechanical devices) for managing pelvic organ prolapse in women. Cochrane Database Syst Rev. 2020;11:CD004010. doi:10.1002/14651858.CD004010.pub4
  • The American College of Obstetricians and Gynecologists and the American Urogynecologic Society. INTERIM UPDATE: this practice bulletin is updated as highlighted to reflect the US Food and Drug Administration order to stop the sale of transvaginal synthetic mesh products for the repair of pelvic organ prolapse. Pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2019;25:397–408. doi:10.1097/SPV.0000000000000794
  • Lone F, Thakar R, Sultan AH. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaire. Int Urogyn J. 2015;26:1305–1312. doi:10.1007/s00192-015-2686-9
  • Abdool Z, Thakar R, Sultan AH, Oliver RS. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogyn J. 2011;22:273–278. doi:10.1007/s00192-010-1340-9
  • Coolen AWM, Troost S, Mol BWJ, Roovers JWR, Bongers MY. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery. Int Urogyn J. 2018;29:99–107. doi:10.1007/s00192-017-3372-x
  • Miceli A, Dueñas-Diez JL. Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study. Int Urogynecol J. 2019;30:2161–2169. doi:10.1007/s00192-019-03919-8
  • Sung VW, Wohlrab KJ, Madsen A, Raker C. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2016;215:659.e1–659.e7. doi:10.1016/j.ajog.2016.06.013
  • Mamik MM, Rogers RG, Qualls CR, Komesu YM. Goal attainment after treatment in patients with symptomatic pelvic organ prolapse. Am J Obstet Gynecol. 2013;209:488.e1–488.e5. doi:10.1016/j.ajog.2013.06.011
  • Barber MD, Walters MD, Cundiff GW; PESSRI Trial Group. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol. 2006;194:1492–1498. doi:10.1016/j.ajog.2006.01.076
  • De Boer TA, Gietelink DA, Vierhout ME. Discrepancies between physician interview and a patient self-assessment questionnaire after surgery for pelvic organ prolapse. Int Urogyn J. 2008;19:1349–1352. doi:10.1007/s00192-008-0656-1
  • Price N, Jackson SR, Avery K, Brookes ST, Abrams P. Development and psychometric evaluation of the ICIQ vaginal symptoms questionnaire: the ICIQ-VS. BJOG. 2006;113:700–712. doi:10.1111/j.1471-0528.2006.00938.x
  • Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S. P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J. 2005;16:176–181. doi:10.1007/s00192-004-1225-x
  • Madhu C, Swift S, Moloney GS, Drake MJ. How to use the Pelvic Organ Prolapse Quantification (POP-Q) system. Neurourol Urodyn. 2018;37:39–43. doi:10.1002/nau.23740
  • Sriwat W, Manonai J, Sillaphakit C, Sarit-apirak S, Chittacharoen A. Validation of the Thai version of ICIQ-VS (international consultation on incontinence questionnaire -vaginal symptoms) in Thai women. Rama Med J. 2016;39:1–3.
  • Manchana T, Bunyavejchevin S. Validation of the Prolapse Quality of Life (P-QOL) questionnaire in Thai version. Int Urogyn J. 2010;21:985–993. doi:10.1007/s00192-010-1107-3
  • Bodner-Adler B, Bodner K, Stinglmeier A, et al. Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment? Arch Gynecol Obstet. 2019;299:773–777. doi:10.1007/s00404-019-05046-7
  • Sung VW, Rogers RG, Barber MD, Clark MA. Conceptual framework for patient-important outcomes for pelvic organ prolapse. Neurourol Urodyn. 2014;33:414–419. doi:10.1002/nau.22397
  • Lee H, Vlaev I, King D, Mayer E, Darzi A, Dolan P. Subjective well-being and the measurement of quality in healthcare. Soc Sci Med. 2013;99:27–34. doi:10.1016/j.socscimed.2013.09.027
  • Cichowski S, Grzybowska ME, Halder GE, et al. International urogynecology consultation: patient reported outcome measures (PROs) use in the evaluation of patients with pelvic organ prolapse. Int Urogynecol J. 2022;33(10):2603–2631. doi:10.1007/s00192-022-05315-1
  • Albuquerque Coelho SC, Castro EB, Juliato CR. Female pelvic organ prolapse using pessaries: systematic review. Int Urogynecol J. 2016;27:1797–1803. doi:10.1007/s00192-016-2991-y